Home›People›Henrik Rasmussen
HR

Henrik Rasmussen

Director at Renibus Therapeutics.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Jul 17, 2025·Suggest an edit

About Henrik Rasmussen

Henrik Rasmussen is a director at Renibus Therapeutics.

Henrik Rasmussen reports to the SEC as an officer of 3 public companies: Allakos (ALLK), ZS Pharma (ZSPH) and Vaxart (VXRT).

Henrik Rasmussen first appears on SEC filings in 2006.

Experience

This experience comes from SEC filings. The years are when the filings name Henrik Rasmussen in the role, so the role may have started earlier or lasted longer.

Renibus Therapeutics, Inc.
Director
2019 – 2025 · Southlake, TX
Allakos Inc.
Chief Medical Officer
2018 – 2021 · Public company (ALLK)
ZS Pharma, Inc.
Chief Medical Officer
2014 – 2015 · Public company (ZSPH)
Vaxart, Inc.
Sr. VP Clin. Med. & Reg. Affs
2006 – 2007 · Public company (VXRT)

Key Colleagues at Startups

The people Henrik Rasmussen works with at each company, as listed on that company's latest Form D.

Renibus Therapeutics, Inc. · Form D/A, Jul 17, 2025
JD
Jamie Donadio
Executive officer
BS
Bhupinder Singh
Executive officer and director
CG
DK
D. Keyser
Chief Executive Officer and director

Sources

  1. SECRenibus Therapeutics, Inc. Form D/A, filed Jul 17, 2025
  2. SECForms 3, 4 and 5 filed by Henrik Rasmussen (SEC filer 1271905)